检索结果 - Richard M. Sherry

Refine Results
  1. 1
    Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma

    Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma 由 Liqiang Xi, Trinh H. Pham, Eden C. Payabyab, Richard M. Sherry, Steven A. Rosenberg, Mark Raffeld

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy

    Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy 由 Jenny J. Hong, Steven A. Rosenberg, Mark E. Dudley, James Chih‐Hsin Yang, Donald E. White, John A. Butman, Richard M. Sherry

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Determination of the Elimination Half-Life of Fibroblast Growth Factor-23

    Determination of the Elimination Half-Life of Fibroblast Growth Factor-23 由 Azarmindokht Khosravi, Carolee M. Cutler, Marilyn H Kelly, Richard Chang, Richard E. Royal, Richard M. Sherry, Felasfa M. Wodajo, Neal S. Fedarko, Michael T. Collins

    出版 2007
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

    Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy 由 Kathryn M. Cappell, Richard M. Sherry, James C. Yang, Stephanie L. Goff, Danielle Vanasse, Lori McIntyre, Steven A. Rosenberg, James N. Kochenderfer

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma

    CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma 由 Peter A. Prieto, James Chih‐Hsin Yang, Richard M. Sherry, Marybeth S. Hughes, Udai S. Kammula, Donald E. White, Catherine Lévy, Steven A. Rosenberg, Giao Q. Phan

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

    A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer 由 James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Seth M. Steinberg, Helen X. Chen, Steven A. Rosenberg

    出版 2003
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

    Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma 由 Richard E. Royal, Catherine Lévy, Keli Turner, Aarti Mathur, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Israel Lowy, Steven A. Rosenberg

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma

    High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma 由 Jacob A. Klapper, Stephanie G. Downey, Franz O. Smith, James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Richard E. Royal, Seth M. Steinberg, Steven A. Rosenberg

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL

    Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL 由 Stephanie L. Goff, Franz O. Smith, Jacob A. Klapper, Richard M. Sherry, John R. Wunderlich, Seth M. Steinberg, Donald White, Steven A. Rosenberg, Mark E. Dudley, James C. Yang

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy

    Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy 由 James N. Kochenderfer, Robert Somerville, Tangying Lu, James C. Yang, Richard M. Sherry, Steven A. Feldman, Lori McIntyre, Adrian Bot, John M. Rossi, Norris Lam, Steven A. Rosenberg

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases

    Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases 由 Gautam U. Mehta, Parisa Malekzadeh, Thomas E. Shelton, Donald E. White, John A. Butman, James Chih‐Hsin Yang, Udai S. Kammula, Stephanie L. Goff, Steven A. Rosenberg, Richard M. Sherry

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response

    Localization of111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with respo... 由 Barbara A. Pockaj, Richard M. Sherry, John P. Wei, John R. Yannelli, Charles S. Carter, Susan F. Leitman, Jorge A. Carasquillo, Seth M. Steinberg, Steven A. Rosenberg, James Chih‐Hsin Yang

    出版 1994
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer

    Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer 由 Joseph Blansfield, Kimberly E Beck, Khoi Tran, James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Suzanne L. Topalian, Leah Haworth, Catherine Lévy, Steven A. Rosenberg, Richard M. Sherry

    出版 2005
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans

    Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans 由 Smita S. Chandran, Biman C. Paria, Abhishek K. Srivastava, Luke D. Rothermel, Daniel J. Stephens, Mark E. Dudley, Robert Somerville, John R. Wunderlich, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Udai S. Kammula

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study

    T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study 由 Stacey L. Doran, Sanja Stevanović, Sabina Adhikary, Jared J. Gartner, Li Jia, Mei Li M. Kwong, William C. Faquin, Stephen M. Hewitt, Richard M. Sherry, James C. Yang, Steven A. Rosenberg, Christian S. Hinrichs

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

    Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis 由 James Chih‐Hsin Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Richard M. Sherry, Suzanne L. Topalian, Kimberly B. Suri, Catherine Lévy, Tamika Allen, Sharon Mavroukakis, Israel Lowy, Donald E. White, Steven A. Rosenberg

    出版 2007
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma

    Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma 由 Ajay V. Maker, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Udai S. Kammula, Richard E. Royal, Marybeth S. Hughes, Michael Yellin, Leah Haworth, Catherine Lévy, Tamika Allen, Sharon Mavroukakis, Peter Attia, Steven A. Rosenberg

    出版 2006
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen

    Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen 由 Steven A. Rosenberg, James C. Yang, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian, Douglas J. Schwartzentruber, Nicholas P. Restifo, Leah Haworth, Claudia A. Seipp, Linda J. Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White

    出版 2003
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines

    Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines 由 Franz O. Smith, Stephanie G. Downey, Jacob A. Klapper, James C. Yang, Richard M. Sherry, Richard E. Royal, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Catherine Lévy, Donald E. White, Seth M. Steinberg, Steven A. Rosenberg

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

    Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study 由 Ajay V. Maker, Giao Q. Phan, Peter Attia, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Udai S. Kammula, Richard E. Royal, Leah Haworth, Catherine Lévy, David E. Kleiner, Sharon Mavroukakis, Michael Yellin, Steven A. Rosenberg

    出版 2005
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: